Daring to Dream
Eli Lilly's experimental drug-known as LY2140023-promises to reduce schizophrenic symptoms by acting on glutamate, a key transmitter in the brain that is a critical link in circuits involved in memory, learning and perception. With possibly fewer side effects than Zyprexa, this new drug appeared to improve cognition, something the second... Read more












